Nathan T.

Nathan T. is an experienced executive in the biomedical and medical industries, currently serving as the President Director of PT. Brightgene Biomedical Indonesia since September 2023 and concurrently as the President Commissioner of PT. UBC Medical Indonesia and the President Director of PT Etana Biotechnologies Indonesia since 2014. Prior roles include Managing Director at PT Inodia and Head of International Sales at Shanghai United Cell Biotechnology Co., Ltd., where Nathan also held the position of Regional Sales Manager. Additional experience includes General Manager at Asia United (China) Medical Company and various roles at sanofi-aventis and Elanco. Nathan T. holds a Graduate Certificate in Marketing from the University of Technology Sydney and a Bachelor of Engineering in Industrial Engineering from UNSW.